Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-033413
Filing Date
2013-06-24
Accepted
2013-06-24 17:00:21
Documents
1
Period of Report
2013-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4224
  Complete submission text file 0001209191-13-033413.txt   5613
Mailing Address C/O MEDAREX, INC 707 STATE ROAD PRINCETON NJ 08540
Business Address
PIEN HOWARD H (Reporting) CIK: 0001187152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 13930160

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations